Stock Events

Stock Events

Inhibikase Therapeutics (IKT) Q4 2022 Earnings

30MarExpected

May 22

Aug 22

Nov 22

Q4 2022

-0.19

-0.13

-0.06

0

Details

Expected EPS

-0.19

Actual EPS

0

Surprise EPS

0.19

Surprise Percent

+100%

Description

Inhibikase Therapeutics (IKT) will report earnings of for Q4 2022 on March 30, 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.